JP2001506904A5 - - Google Patents

Download PDF

Info

Publication number
JP2001506904A5
JP2001506904A5 JP1998528903A JP52890398A JP2001506904A5 JP 2001506904 A5 JP2001506904 A5 JP 2001506904A5 JP 1998528903 A JP1998528903 A JP 1998528903A JP 52890398 A JP52890398 A JP 52890398A JP 2001506904 A5 JP2001506904 A5 JP 2001506904A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998528903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001506904A (ja
JP4153999B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/023274 external-priority patent/WO1998028037A1/en
Publication of JP2001506904A publication Critical patent/JP2001506904A/ja
Publication of JP2001506904A5 publication Critical patent/JP2001506904A5/ja
Application granted granted Critical
Publication of JP4153999B2 publication Critical patent/JP4153999B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP52890398A 1996-12-20 1997-12-16 経皮作用剤流量を強化するための組成物と方法 Expired - Fee Related JP4153999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3344096P 1996-12-20 1996-12-20
US60/033,440 1996-12-20
PCT/US1997/023274 WO1998028037A1 (en) 1996-12-20 1997-12-16 Device and method for enhancing transdermal agent flux

Publications (3)

Publication Number Publication Date
JP2001506904A JP2001506904A (ja) 2001-05-29
JP2001506904A5 true JP2001506904A5 (cg-RX-API-DMAC10.html) 2005-06-16
JP4153999B2 JP4153999B2 (ja) 2008-09-24

Family

ID=21870407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52890398A Expired - Fee Related JP4153999B2 (ja) 1996-12-20 1997-12-16 経皮作用剤流量を強化するための組成物と方法

Country Status (11)

Country Link
EP (1) EP0957972B1 (cg-RX-API-DMAC10.html)
JP (1) JP4153999B2 (cg-RX-API-DMAC10.html)
KR (1) KR100453132B1 (cg-RX-API-DMAC10.html)
CN (1) CN1133472C (cg-RX-API-DMAC10.html)
AT (1) ATE234649T1 (cg-RX-API-DMAC10.html)
AU (1) AU722574B2 (cg-RX-API-DMAC10.html)
CA (1) CA2271167C (cg-RX-API-DMAC10.html)
DE (1) DE69720057T2 (cg-RX-API-DMAC10.html)
DK (1) DK0957972T3 (cg-RX-API-DMAC10.html)
ES (1) ES2195190T3 (cg-RX-API-DMAC10.html)
WO (1) WO1998028037A1 (cg-RX-API-DMAC10.html)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812150A4 (en) 1995-12-28 1999-03-10 Cygnus Therapeutic Systems CONTINUOUS CONTROL OF A PHYSIOLOGICAL ANALYTE
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
US6322808B1 (en) 1997-12-11 2001-11-27 Alza Corporation Device for enhancing transdermal agent flux
CN1170603C (zh) * 1997-12-11 2004-10-13 阿尔扎有限公司 增强透皮物剂流量的装置
US7066884B2 (en) 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
EP1109594B1 (en) * 1998-08-31 2004-10-27 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
HK1044484B (en) 1999-04-19 2005-07-29 Smithkline Beecham Biologicals S.A. Adjuvant composition containing saponin and immunostimulatory oligonucleotide
US6558670B1 (en) 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
WO2000074763A2 (en) * 1999-06-04 2000-12-14 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
CA2376368C (en) * 1999-06-08 2009-08-11 Altea Technologies, Inc. Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
WO2001041864A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Skin treatment apparatus for sustained transdermal drug delivery
HK1048604B (en) 1999-12-10 2006-05-04 Alza Corporation Device and method for enhancing microprotrusion skin piercing
US6622035B1 (en) 2000-01-21 2003-09-16 Instrumentarium Corp. Electrode for measurement of weak bioelectrical signals
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
MXPA03001694A (es) * 2000-08-24 2004-11-01 Johnson & Johnson Metodo para toma de muestra transdermal de acido nucleico.
US6749575B2 (en) 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
CN100421653C (zh) 2000-09-08 2008-10-01 阿尔扎公司 通过抑制通道关闭来抑制药物透皮通量减少的方法
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
PL360978A1 (en) 2000-10-13 2004-09-20 Alza Corporation Microblade array impact applicator
PT1341452E (pt) * 2000-10-13 2009-03-18 Alza Corp Meio de retenção de elemento com microsaliências para aplicador por impacto
JP4659332B2 (ja) 2000-10-13 2011-03-30 アルザ・コーポレーシヨン 微小突起を用いて皮膚を穿孔するための装置および方法
US6821281B2 (en) * 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
DE60131670T2 (de) 2000-10-18 2008-10-30 Glaxosmithkline Biologicals S.A. Impfstoffe gegen Krebskrankheiten
US7537795B2 (en) 2000-10-26 2009-05-26 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
US7027478B2 (en) 2000-12-21 2006-04-11 Biovalve Technologies, Inc. Microneedle array systems
WO2002074173A1 (en) 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
EP3251722B1 (en) 2001-04-20 2020-06-17 ALZA Corporation Microprojection array having a beneficial agent containing coating and method of forming the coating thereon
KR20040020889A (ko) * 2001-04-20 2004-03-09 알자 코포레이션 유용한 약물을 갖는 코팅을 포함하는 미세돌출부 어레이
US8361037B2 (en) 2001-09-19 2013-01-29 Valeritas, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
ATE498418T1 (de) 2001-09-21 2011-03-15 Valeritas Inc Durch gasdruck betätigte mikronadel-anordnungen und damit zusammenhängende systeme und verfahren
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
US7392080B2 (en) * 2002-03-11 2008-06-24 Altea Therapeutics Corporation Transdermal drug delivery patch system, method of making same and method of using same
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
ES2437565T3 (es) 2003-06-30 2014-01-13 Alza Corporation Formulaciones para microproyecciones revestidas que contienen contraiones no volátiles
US8353861B2 (en) 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
JP2007510445A (ja) * 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
US7455654B2 (en) 2003-10-28 2008-11-25 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
WO2005044333A2 (en) 2003-10-31 2005-05-19 Alza Corporation Self-actuating applicator for microprojection array
KR20070010115A (ko) * 2003-11-13 2007-01-22 알자 코포레이션 경피전달용 조성물 및 장치
WO2005051476A1 (en) * 2003-11-28 2005-06-09 Acrux Dds Pty Ltd Method and system for rapid transdermal administration
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
MX2007001667A (es) * 2004-08-11 2007-10-02 Johnson & Johnson Aparato y metodo para el suministro transdermico de peptidos natriureticos.
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
WO2006089056A2 (en) * 2005-02-16 2006-08-24 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
CN100591293C (zh) * 2005-03-28 2010-02-24 阿尔扎公司 具有毛细控制部件的微突物和方法
JP2008543528A (ja) * 2005-06-27 2008-12-04 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルカートリッジアセンブリ及び適用方法
US7432069B2 (en) 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
EA014107B1 (ru) 2005-12-22 2010-10-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
US8632801B2 (en) 2005-12-28 2014-01-21 Alza Corporation Stable therapeutic formulations
BRPI0710210A2 (pt) 2006-03-30 2011-05-24 Glaxomithkline Biolog S A composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular
WO2007124393A2 (en) * 2006-04-20 2007-11-01 3M Innovative Properties Company Molded articles comprising microneedle arrays
DE102006028987A1 (de) * 2006-06-24 2007-12-27 Lts Lohmann Therapie-Systeme Ag Ultraschallverstärktes transdermales therapeutisches System
CN101522218B (zh) 2006-10-12 2012-09-26 葛兰素史密丝克莱恩生物有限公司 包含水包油乳液佐剂的疫苗
EP2086582B1 (en) 2006-10-12 2012-11-14 GlaxoSmithKline Biologicals s.a. Vaccine comprising an oil in water emulsion adjuvant
DE602008005299D1 (de) 2007-04-27 2011-04-14 Echo Therapeutics Inc Hautpermeationsvorrichtung für Analytenmessung oder transdermale Arzneiabgabe
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2153863B1 (en) 2007-05-15 2022-03-16 Hisamitsu Pharmaceutical Co., Inc. Method of coating microneedle
US20100183662A1 (en) 2007-06-26 2010-07-22 Ralph Leon Biemans Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CA2745339C (en) 2007-12-24 2016-06-28 The University Of Queensland Coating method
AU2009212106B9 (en) 2008-02-07 2014-05-22 Vaxxas Pty Limited Patch production
GB0802447D0 (en) * 2008-02-09 2008-03-19 Univ Manchester Fluid extraction device, associated materials and methods
PT2271360E (pt) 2008-04-16 2015-12-07 Glaxosmithkline Biolog Sa Vacina
WO2009140735A1 (en) * 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents.
CN102223876A (zh) 2008-09-26 2011-10-19 纳米生物公司 纳米乳剂治疗性组合物及其使用方法
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
JP5902390B2 (ja) 2008-12-26 2016-04-13 久光製薬株式会社 マイクロニードルデバイス
US20120004626A1 (en) 2009-01-30 2012-01-05 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
EP2441437B1 (en) 2009-06-10 2018-08-08 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
CA2765511C (en) 2009-06-16 2015-05-12 The Regents Of The University Of Michigan Nanoemulsion vaccines
EP2457592B1 (en) 2009-07-23 2020-09-16 Hisamitsu Pharmaceutical Co., Inc. Microneedle array
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2540337B1 (en) 2010-02-24 2019-04-03 Hisamitsu Pharmaceutical Co., Inc. Micro-needle device and preparation method
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
KR101741294B1 (ko) 2010-05-28 2017-05-29 히사미쓰 세이야꾸 가부시키가이샤 미소 돌기가 형성된 어레이를 갖는 디바이스
EP2578265B1 (en) 2010-05-28 2019-04-03 Hisamitsu Pharmaceutical Co., Inc. Array with fine protrusions
US8658603B2 (en) 2010-06-16 2014-02-25 The Regents Of The University Of Michigan Compositions and methods for inducing an immune response
US9943673B2 (en) 2010-07-14 2018-04-17 Vaxxas Pty Limited Patch applying apparatus
EP2679270B1 (en) 2011-02-24 2016-11-09 Hisamitsu Pharmaceutical Co., Inc. Glp-1 analogue composition for microneedle devices
US8696637B2 (en) * 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
AU2012323782B2 (en) 2011-10-12 2017-04-06 Vaxxas Pty Limited Delivery device
CA2851606C (en) 2011-10-12 2020-08-04 3M Innovative Properties Company Integrated microneedle array delivery system
JP2013153959A (ja) * 2012-01-30 2013-08-15 Toppan Printing Co Ltd 針状体の構造
CN103356243A (zh) * 2012-03-27 2013-10-23 马广 新型皮肤采样器
PL2912186T3 (pl) 2012-10-24 2021-06-14 Platelet Targeted Therapeutics Llc Leczenie ukierunkowane na płytki krwi
WO2015017561A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-profile microneedle patch applicator
CN105992770B (zh) 2013-11-01 2021-06-25 奥斯陆大学 白蛋白的变体及其用途
CA2929126C (en) 2013-11-13 2020-01-07 University Of Oslo Outer membrane vesicles and uses thereof
DK3069138T3 (en) 2013-11-15 2019-04-08 Univ Oslo Hf CTL PEPTID EPITOPES AND ANTIGEN-SPECIFIC T-CELLS, METHODS OF RECOGNITION THEREOF, AND APPLICATIONS THEREOF
EP4112076A1 (en) 2014-10-10 2023-01-04 The Regents of The University of Michigan Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
WO2016123665A1 (en) 2015-02-02 2016-08-11 Vaxxas Pty Limited Microprojection array applicator and method
EP3268034A4 (en) 2015-03-05 2018-11-14 Northwestern University Non-neuroinvasive viruses and uses thereof
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
US20180264244A1 (en) 2015-09-28 2018-09-20 Vaxxas Pty Limited Microprojection arrays with enhanced skin penetrating properties and methods thereof
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
EP3454891A4 (en) 2016-05-10 2019-12-25 The Regents of The University of Michigan EMULSION ADJUVANS FOR INTRAMUSCULAR, INTRADERMAL AND SUBCUTANEOUS ADMINISTRATION
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
WO2018096396A1 (en) 2016-11-22 2018-05-31 University Of Oslo Albumin variants and uses thereof
KR102274352B1 (ko) 2016-12-26 2021-07-06 히사미쓰 세이야꾸 가부시키가이샤 마이크로니들 디바이스
US11464956B2 (en) 2017-02-24 2022-10-11 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
CN115923337A (zh) 2017-03-31 2023-04-07 瓦克萨斯私人有限公司 用于涂覆表面的设备和方法
CA3065371A1 (en) 2017-06-13 2018-12-20 Vaxxas Pty Limited Quality control of substrate coatings
EP4327876A3 (en) 2017-06-23 2024-05-22 Affinivax, Inc. Immunogenic compositions
EP4548954A3 (en) 2017-08-04 2025-07-30 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)
EP3678698A1 (en) 2017-09-07 2020-07-15 University Of Oslo Vaccine molecules
US12005112B2 (en) 2017-09-07 2024-06-11 University Of Oslo Vaccine molecules
CN111615397B (zh) 2017-11-03 2024-09-13 武田疫苗股份有限公司 寨卡疫苗和免疫原性组合物及其使用方法
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
ES2964349T3 (es) 2018-06-26 2024-04-05 Hisamitsu Pharmaceutical Co Dispositivo de microagujas y método para la fabricación del mismo
JP7399295B2 (ja) * 2020-04-06 2023-12-15 イルロン カンパニー リミテッド 化粧品吸収誘導用微細針が取り付けられた化粧品注入器及びその制作方法
US20230233667A1 (en) 2021-09-08 2023-07-27 Affinivax, Inc. Coronavirus vaccine
WO2024229176A1 (en) 2023-05-04 2024-11-07 Affinivax, Inc. Rhizavidin variants
WO2025193903A1 (en) 2024-03-15 2025-09-18 Affinivax, Inc. Pneumococcal polysaccharide compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
ES2082973T3 (es) 1990-03-30 1996-04-01 Alza Corp Dispositivo para administracion iontoforetica de farmacos.
KR930702043A (ko) 1990-10-29 1993-09-08 에드워드 엘. 맨델 이온 영동 약물 전달 전극 및 그의 수화 방법
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
CA2205444A1 (en) * 1994-12-09 1996-06-13 Novartis Ag Transdermal system
AU5869796A (en) * 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem

Similar Documents

Publication Publication Date Title
JP2000504575A5 (cg-RX-API-DMAC10.html)
JP2000512744A5 (cg-RX-API-DMAC10.html)
JP2000511776A5 (cg-RX-API-DMAC10.html)
JP2000515269A5 (cg-RX-API-DMAC10.html)
JP2000515550A5 (cg-RX-API-DMAC10.html)
JP2001506904A5 (cg-RX-API-DMAC10.html)
JP2000507473A5 (cg-RX-API-DMAC10.html)
JP2001502526A5 (cg-RX-API-DMAC10.html)
JP2000504949A5 (cg-RX-API-DMAC10.html)
JP2000504881A5 (cg-RX-API-DMAC10.html)
JP2001524993A5 (cg-RX-API-DMAC10.html)
JP2000509988A5 (cg-RX-API-DMAC10.html)
JP2000508601A5 (cg-RX-API-DMAC10.html)
JP2001509011A5 (cg-RX-API-DMAC10.html)
JP2000503844A5 (cg-RX-API-DMAC10.html)
JP2000511806A5 (cg-RX-API-DMAC10.html)
JP2000514170A5 (cg-RX-API-DMAC10.html)
JP2002515145A5 (cg-RX-API-DMAC10.html)
JP2000506724A5 (cg-RX-API-DMAC10.html)
JP2000507463A5 (cg-RX-API-DMAC10.html)
JP2002502363A5 (cg-RX-API-DMAC10.html)
JP2000503912A5 (cg-RX-API-DMAC10.html)
JP2000506091A5 (cg-RX-API-DMAC10.html)
JP2002508089A5 (cg-RX-API-DMAC10.html)
JP2000516933A5 (cg-RX-API-DMAC10.html)